Improving Medication Safety in Chronic Kidney Disease Patients on Dialysis Through Medication Reconciliation

Advances in Chronic Kidney Disease

Volumn 17, Issue 5, 2010, Pages 413-419

  St Peter, Wendy L ^a,b,c  

^a UNIVERSITY OF MINNESOTA   (United States)

^b MINNEAPOLIS MEDICAL RESEARCH FOUNDATION   (United States)

^c MINNEAPOLIS MEDICAL RESEARCH FOUNDATION   (United States)

Author keywords

Dialysis; Medication reconciliation; Medication related problems; Multidisciplinary teams

Indexed keywords

CALCIUM ACETATE; CALCIUM PHOSPHATE; HERBACEOUS AGENT; NON PRESCRIPTION DRUG; VITAMIN;

CHRONIC KIDNEY DISEASE; DRUG SAFETY; HEMODIALYSIS; HERBAL MEDICINE; HOSPITALIZATION; HUMAN; MEDICAL INFORMATION; PATIENT CARE; PATIENT COMPLIANCE; PATIENT SAFETY; PERITONEAL DIALYSIS; PHARMACIST; PRIORITY JOURNAL; REVIEW; TREATMENT OUTCOME;

EID: 77955829240     PISSN: 15485595     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.ackd.2010.06.001     Document Type: Review

References (39)

1. St Peter W.L., Schoolwerth A.C., McGowan T., et al. Chronic kidney disease: Issues and establishing programs and clinics for improved patient outcomes. Am J Kidney Dis 2003, 41:903-924.
2. Kaplan B., Mason N.A., Shimp L.A., et al. Chronic hemodialysis patients. Part I: Characterization and drug-related problems. Ann Pharmacother 1994, 28:316-319.
3. Manley H.J., Cannella C.A., Bailie G.R., et al. Medication-related problems in ambulatory hemodialysis patients: A pooled analysis. Am J Kidney Dis 2005, 46:669-680.
4. Grabe D.W., Low C.L., Bailie G.R., et al. Evaluation of drug-related problems in an outpatient hemodialysis unit and the impact of a clinical pharmacist. Clin Nephrol 1997, 47:117-121.
5. Manley H.J., Drayer D.K., McClaran M., et al. Drug record discrepancies in an outpatient electronic medical record: Frequency, type, and potential impact on patient care at a hemodialysis center. Pharmacotherapy 2003, 23:231-239.
6. Manley H.J., McClaran M.L., Overbay D.K., et al. Factors associated with medication-related problems in ambulatory hemodialysis patients. Am J Kidney Dis 2003, 41:386-393.
7. Leendertse A.J., Egberts A.C., Stoker L.J., et al. Frequency of and risk factors for preventable medication-related hospital admissions in the Netherlands. Arch Intern Med 2008, 168:1890-1896.
8. Possidente C.J., Bailie G.R., Hood V.L. Disruptions in drug therapy in long-term dialysis patients who require hospitalization. Am J Health Syst Pharm 1999, 56:1961-1964.
9. Wong J.D., Bajcar J.M., Wong G.G., et al. Medication reconciliation at hospital discharge: Evaluating discrepancies. Ann Pharmacother 2008, 42:1373-1379.
10. Vira T., Colquhoun M., Etchells E. Reconcilable differences: Correcting medication errors at hospital admission and discharge. Qual Saf Health Care 2006, 15:122-126.
11. Nickerson A., MacKinnon N.J., Roberts N., et al. Drug-therapy problems, inconsistencies and omissions identified during a medication reconciliation and seamless care service. Healthc Q 2005, 8 Spec No:65-72.
12. Ong S.W., Fernandes O.A., Cesta A., et al. Drug-related problems on hospital admission: Relationship to medication information transfer. Ann Pharmacother 2006, 40:408-413.
13. USRDS 2009 Annual Data Report: Atlas of Chronic Kidney Disease and End-Stage Renal Disease in the United States 2009, U.S. Renal Data System, National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda, MD.
14. Institute for Healthcare Improvement: Prevent Adverse Drug Events (Medication Reconciliation). Institute for Healthcare Improvement (IHI) website. Available at: Accessed February 23, 2010. http://www.ihi.org/IHI/Programs/Campaign/ADEsMedReconciliation.htm.
15. Institute for Safe Medication Practices: ISMP Medication Safety. Institute for Safe Medication Practices website. Available at: Accessed February 23, 2010. http://www.ismp.org/newsletters/acutecare/articles/20050421.asp.
16. The Joint Commission: Sentinel Event Alert #35. Using medication reconciliation to prevent errors. The Joint Commission website. Available at: Accessed February 23, 2010. http://www.jointcommission.org/SentinelEvents/SentinelEventAlert/sea_35.htm.
17. Winkelmayer W.C., Levin R., Setoguchi S. Associations of kidney function with cardiovascular medication use after myocardial infarction. Clin J Am Soc Nephrol 2008, 3:1415-1422.
18. Morisky D.E., Green L.W., Levine D.M. Concurrent and predictive validity of a self-reported measure of medication adherence. Med Care 1986, 24:67-74.
19. Rosengren D.B. Building Motivational Interviewing Skills. A Practitioner Workbook 2009, Guilford Press, New York, NY.
20. Rollnick S., Miller W.R. Motivational Interviewing in Health Care. Helping Patients Change Behavior 2007, Guilford Press, New York, NY.
21. Tam V.C., Knowles S.R., Cornish P.L., et al. Frequency, type and clinical importance of medication history errors at admission to hospital: A systematic review. CMAJ 2005, 173:510-515.
22. La Verde S. Evaluation of drug history program. Hospitals 1973, 47:106.
23. Montpetit L.M., Roy M.T. Evaluation of a patient-completed versus health professional-conducted medication history. Drug Intell Clin Pharm 1988, 22:964-969.
24. Barger R.C., Barger J. Pharmacist, nurse cooperate in taking drug histories. Hospitals 1976, 50:93-94.
25. Schnipper J.L., Kirwin J.L., Cotugno M.C., et al. Role of pharmacist counseling in preventing adverse drug events after hospitalization. Arch Intern Med 2006, 166:565-571.
26. Schnipper J.L., Hamann C., Ndumele C.D., et al. Effect of an electronic medication reconciliation application and process redesign on potential adverse drug events: A cluster-randomized trial. Arch Intern Med 2009, 169:771-780.
27. Jack B.W., Chetty V.K., Anthony D., et al. A reengineered hospital discharge program to decrease rehospitalization: A randomized trial. Ann Intern Med 2009, 150:178-187.
28. Walker P.C., Bernstein S.J., Jones J.N., et al. Impact of a pharmacist-facilitated hospital discharge program: A quasi-experimental study. Arch Intern Med 2009, 169:2003-2010.
29. Brady A.M., Malone A.M., Fleming S. A literature review of the individual and systems factors that contribute to medication errors in nursing practice. J Nurs Manag 2009, 17:679-697.
30. Massachusetts Coalition for the Prevention of Medical Errors: Reconciling medications safe practice recommendations and implementation tools, 2010. MassachusettsCoalition for the Prevention of Medical Errors website. Available at: Accessed May, 25 2010. http://www.macoalition.org/documents/RecMedPractices_3_7_08.pdf.
31. Institute for Healthcare Improvement: Medication Reconciliation Tools. Institute for Healthcare Improvement website. Available at: Accessed May 25, 2010. http://www.ihi.org/IHI/Topics/PatientSafety/MedicationSystems/Tools/%23Medication.
32. Medicare Payment Advisory Commission: Report to the Congress: Medicare Payment Policy. Medicare Payment Advisory Commission (MEDPAC) website. Available at: Accessed March 1, 2010. http://www.medpac.gov/documents/Mar10_EntireReport.pdf.
33. Centers for Medicare and Medicaid Services: Medicare Programs; End-Stage Renal Disease Prospective Payment System (42 CFR Part 410, 413 and 414;[CMS-1418-P]; RIN 0938-AP57). Northwest Kidney Centers website. Available at: Accessed March 1, 2010. http://www.nwkidney.org/nkc/kidneyInformation/legislation/Medicare_proposal_2009.pdf.
34. Riley K.D., Wazny L.D. Assessment of a fax document for transfer of medication information to family physicians and community pharmacists caring for hemodialysis outpatients. CANNT J 2006, 16:24-28.
35. Mirkov S. Implementation of a pharmacist medication review clinic for haemodialysis patients. N Z Med J 2009, 122:25-37.
36. Nguyen T.V. The consultant pharmacist's role in dialysis: An introduction. Consult Pharm 2007, 22:1035-1044.
37. Joy M.S., DeHart R.M., Gilmartin C., et al. Clinical pharmacists as multidisciplinary health care providers in the management of CKD: A joint opinion by the Nephrology and Ambulatory Care Practice and Research Networks of the American College of Clinical Pharmacy. Am J Kidney Dis 2005, 45:1105-1118.
38. Pai A.B., Boyd A., Chavez A., et al. Health-related quality of life is maintained in hemodialysis patients receiving pharmaceutical care: A 2-year randomized, controlled study. Hemodial Int 2009, 13:72-79.
39. Manley H.J., Carroll C.A. The clinical and economic impact of pharmaceutical care in end-stage renal disease patients. Semin Dial 2002, 15:45-49.